Emerging Applications of Tumour-educated Platelets in the Detection and Prognostication of Ovarian Cancer

Overview

Journal Protein Cell

Publisher Oxford University Press

Specialties Biochemistry
Cell Biology

Date 2023 Mar 27

PMID 36971351

Authors

Jiewei Zhu

Vasily Giannakeas

Steven A Narod

Mohammad R Akbari

Affiliations

Soon will be listed here.

References

Dovizio M, Ballerini P, Fullone R, Tacconelli S, Contursi A, Patrignani P . Multifaceted Functions of Platelets in Cancer: From Tumorigenesis to Liquid Biopsy Tool and Drug Delivery System. Int J Mol Sci. 2020; 21(24). PMC: 7765591. DOI: 10.3390/ijms21249585. View

Passiglia F, Rizzo S, Di Maio M, Galvano A, Badalamenti G, Listi A . The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis. Sci Rep. 2018; 8(1):13379. PMC: 6127187. DOI: 10.1038/s41598-018-30780-4. View

Lomnytska M, Pinto R, Becker S, Engstrom U, Gustafsson S, Bjorklund C . Platelet protein biomarker panel for ovarian cancer diagnosis. Biomark Res. 2018; 6:2. PMC: 5767003. DOI: 10.1186/s40364-018-0118-y. View

Stone R, Nick A, McNeish I, Balkwill F, Han H, Bottsford-Miller J . Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med. 2012; 366(7):610-8. PMC: 3296780. DOI: 10.1056/NEJMoa1110352. View

Gao Y, Liu C, Li H, Xiong X, Li G, In t Veld S . Platelet RNA enables accurate detection of ovarian cancer: an intercontinental, biomarker identification study. Protein Cell. 2023; 14(6):579-590. PMC: 10246718. DOI: 10.1093/procel/pwac056. View

Sabatier R, Garnier S, Guille A, Carbuccia N, Pakradouni J, Adelaide J . Whole-genome/exome analysis of circulating tumor DNA and comparison to tumor genomics from patients with heavily pre-treated ovarian cancer: subset analysis of the PERMED-01 trial. Front Oncol. 2022; 12:946257. PMC: 9373051. DOI: 10.3389/fonc.2022.946257. View

Chen L, Wang K, Li L, Zheng B, Zhang Q, Zhang F . Plasma exosomal and as diagnostic biomarkers in epithelial ovarian cancer. Future Oncol. 2022; 18(26):2919-2931. DOI: 10.2217/fon-2022-0321. View

Psaila B, Wang G, Rodriguez-Meira A, Li R, Heuston E, Murphy L . Single-Cell Analyses Reveal Megakaryocyte-Biased Hematopoiesis in Myelofibrosis and Identify Mutant Clone-Specific Targets. Mol Cell. 2020; 78(3):477-492.e8. PMC: 7217381. DOI: 10.1016/j.molcel.2020.04.008. View

Wang T, Gao Y, Wang X, Tian J, Li Y, Yu B . Establishment of an optimized CTC detection model consisting of EpCAM, MUC1 and WT1 in epithelial ovarian cancer and its correlation with clinical characteristics. Chin J Cancer Res. 2022; 34(2):95-108. PMC: 9086574. DOI: 10.21147/j.issn.1000-9604.2022.02.04. View

10.

Liu C, Li H, Gao Y, Xie G, Chi J, Li G . Platelet RNA signature independently predicts ovarian cancer prognosis by deep learning neural network model. Protein Cell. 2023; 14(8):618-622. PMC: 10392027. DOI: 10.1093/procel/pwac053. View

11.

In t Veld S, Arkani M, Post E, Antunes-Ferreira M, DAmbrosi S, Vessies D . Detection and localization of early- and late-stage cancers using platelet RNA. Cancer Cell. 2022; 40(9):999-1009.e6. DOI: 10.1016/j.ccell.2022.08.006. View

12.

Antunes-Ferreira M, Koppers-Lalic D, Wurdinger T . Circulating platelets as liquid biopsy sources for cancer detection. Mol Oncol. 2020; 15(6):1727-1743. PMC: 8169446. DOI: 10.1002/1878-0261.12859. View

13.

Giannakeas V . Trends in platelet count among cancer patients. Exp Hematol Oncol. 2022; 11(1):16. PMC: 8944120. DOI: 10.1186/s40164-022-00272-3. View

14.

Siegel R, Miller K, Fuchs H, Jemal A . Cancer Statistics, 2021. CA Cancer J Clin. 2021; 71(1):7-33. DOI: 10.3322/caac.21654. View

15.

Sol N, Wurdinger T . Platelet RNA signatures for the detection of cancer. Cancer Metastasis Rev. 2017; 36(2):263-272. PMC: 5557864. DOI: 10.1007/s10555-017-9674-0. View

16.

Zhu J, Charkhchi P, Akbari M . Potential clinical utility of liquid biopsies in ovarian cancer. Mol Cancer. 2022; 21(1):114. PMC: 9092780. DOI: 10.1186/s12943-022-01588-8. View